Free Trial

Stock indexes wobble in morning trading on Wall Street

In this July 9, 2020 file photo, the Fearless Girl statue stands in front of the New York Stock Exchange in New York. U.S. stocks edged lower in early trading Tuesday, Dec. 8 as investors worried that rising virus cases will delay a full economic recovery while the world waits for wide distribution of a vaccine. (AP Photo/Mark Lennihan, File)

NEW YORK (AP) — U.S. stocks wavered between small gains and losses in morning trading Tuesday as investors worry that rising virus cases will delay a full economic recovery while the world waits for wide distribution of a vaccine.

The S&P 500 rose 0.1% and remained just below the record high it set on Friday. The Dow Jones Industrial Average rose 71 points, or 0.2%, to 30,141 as of 11:22 a.m. Eastern time. The Nasdaq fell 0.1%.

The U.K. became the first Western country to start a mass vaccination program after British regulators last week authorized the use of a COVID-19 shot developed by U.S. drugmaker Pfizer and Germany’s BioNTech. U.S. health regulators have given a positive initial review of that vaccine and a decision to allow its use is expected within days.

But, wide distribution of any vaccine is likely months away. Meanwhile, governments worldwide have been tightening restrictions on businesses in an effort to stem the latest surge in cases.

Investors are also keeping a close eye on Washington. Congress is still stuck in a partisan stalemate over the size and scope of any additional aid to help cushion the financial impact to people and businesses. The economy has been showing signs of a stalled recovery as the virus surge broadens nationally, including slower job growth in the U.S. last month.

Health care stocks made solid gains. Pfizer rose 2.5% and Johnson & Johnson rose 1.8%. Energy companies also rose while crude oil prices only slightly fell. Exxon rose 33%.

Shop-from-home clothing seller Stitch Fix soared 41.8% after reporting a surprise profit in its latest quarter. Etsy jumped 6.9%.

A mix of companies that rely on direct consumer spending and those that would greatly benefit from a fuller economic reopening fell.

The yield on the 10-year Treasury remained steady at 0.91% from late Monday.

European markets were mixed. France’s CAC 40 was down less than 0.1%, Germany’s DAX lost 0.2% and the FTSE 100 in London rose 0.2%. Asian markets declined.

Should You Invest $1,000 in Pfizer Right Now?

Before you consider Pfizer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pfizer wasn't on the list.

While Pfizer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRankâ„¢Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Johnson & Johnson (JNJ)
4.9385 of 5 stars
$155.38-0.9%3.35%17.28Moderate Buy$171.00
Pfizer (PFE)
4.964 of 5 stars
$24.63-2.9%6.98%17.84Hold$28.55
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines